You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 23, June 17, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Brief Report
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (80)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Lipids and Lipid Disorders
 •Complementary and Alternative Medicine
 •Alert me on articles by topic

Effect of a Garlic Oil Preparation on Serum Lipoproteins and Cholesterol Metabolism

A Randomized Controlled Trial

Heiner K. Berthold, MD, PhD; Thomas Sudhop, MD; Klaus von Bergmann, MD

JAMA. 1998;279:1900-1902.

Context.— Garlic-containing drugs have been used in the treatment of hypercholesterolemia even though their efficacy is not generally established. Little is known about the mechanisms of action of the possible effects on cholesterol in humans.

Objective.— To estimate the hypocholesterolemic effect of garlic oil and to investigate the possible mechanism of action.

Design.— Double-blind, randomized, placebo-controlled trial.

Setting.— Outpatient lipid clinic.

Patients.— We investigated 25 patients (mean age, 58 years) with moderate hypercholesterolemia.

Intervention.— Steam-distilled garlic oil preparation (5 mg twice a day) vs placebo each for 12 weeks with wash-out periods of 4 weeks.

Main Outcome Measures.— Serum lipoprotein concentrations, cholesterol absorption, and cholesterol synthesis.

Results.— Baseline lipoprotein profiles were (mean [SD]): total cholesterol, 7.53 (0.75) mmol/L (291 [29] mg/dL); low-density lipoprotein cholesterol (LDL-C), 5.35 (0.78) mmol/L (207 [30] mg/dL); high-density lipoprotein cholesterol (HDL-C), 1.50 (0.41) mmol/L (58 [16] mg/dL); and triglycerides, 1.45 (0.73) mmol/L (127 [64] mg/dL). Lipoprotein levels were virtually unchanged at the end of both treatment periods (mean difference [95% confidence interval]): total cholesterol, 0.085 (-0.201 to 0.372) mmol/L (3.3 [-7.8 to 14.4] mg/dL), P=.54; LDL-C, 0.001 (-0.242 to 0.245) mmol/L (0.04 [-9.4 to 9.5] mg/dL), P=.99; HDL-C, 0.050 (-0.028 to 0.128) mmol/L (1.9 [-1.1 to 4.9] mg/dL), P=.20; triclycerides, 0.047 (-0.229 to 0.135) mmol/L (4.2 [-20.3 to 12.0]) mg/dL, P=.60. Cholesterol absorption (37.5% [10.5%] vs 38.3% [10.7%], P=.58), cholesterol synthesis (12.7 [6.5] vs 13.4 [6.6] mg/kg of body weight per day, P=.64), mevalonic acid excretion (192 [66] vs 187 [66] µg/d, P=.78), and changes in the ratio of lathosterol to cholesterol in serum (4.4% [24.3%] vs 10.6% [21.1%], P=.62) were not different in garlic and placebo treatment.

Conclusions.— The commercial garlic oil preparation investigated had no influence on serum lipoproteins, cholesterol absorption, or cholesterol synthesis. Garlic therapy for treatment of hypercholesterolemia cannot be recommended on the basis of this study.


From the Department of Clinical Pharmacology, University of Bonn, Bonn, Germany (Drs Berthold, Sudhop, and von Bergmann).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing
McCrindle et al.
Circulation 2007;115:1948-1967.
ABSTRACT | FULL TEXT  

Effect of Raw Garlic vs Commercial Garlic Supplements on Plasma Lipid Concentrations in Adults With Moderate Hypercholesterolemia: A Randomized Clinical Trial
Gardner et al.
Arch Intern Med 2007;167:346-353.
ABSTRACT | FULL TEXT  

Effect of garlic powder on C-reactive protein and plasma lipids in overweight and smoking subjects
van Doorn et al.
Am. J. Clin. Nutr. 2006;84:1324-1329.
ABSTRACT | FULL TEXT  

Influence of Garlic (Allium sativum) on the Pharmacokinetics of Docetaxel
Cox et al.
Clin. Cancer Res. 2006;12:4636-4640.
ABSTRACT | FULL TEXT  

The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%
Franco et al.
BMJ 2004;329:1447-1450.
ABSTRACT | FULL TEXT  

Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents
Sparreboom et al.
JCO 2004;22:2489-2503.
ABSTRACT | FULL TEXT  

Well-Characterized Garlic-Derived Materials Are Not Hypolipidemic in APOE*3-Leiden Transgenic Mice
Espirito Santo et al.
J. Nutr. 2004;134:1500-1503.
ABSTRACT | FULL TEXT  

American College of Cardiology/American Heart Association Clinical Practice Guidelines: Part I: Where Do They Come From?
Gibbons et al.
Circulation 2003;107:2979-2986.
FULL TEXT  

Evaluating Complementary and Alternative Medicine: The Limits of Science and of Scientists
Hufford
J Law Med Ethics 2003;31:198-212.
 

Efficiency of intestinal cholesterol absorption in humans is not related to apoE phenotype
von Bergmann et al.
J. Lipid Res. 2003;44:193-197.
ABSTRACT | FULL TEXT  

Effects on the Human Serum Lipoprotein Profile of {beta}-Glucan, Soy Protein and Isoflavones, Plant Sterols and Stanols, Garlic and Tocotrienols
Kerckhoffs et al.
J. Nutr. 2002;132:2494-2505.
ABSTRACT | FULL TEXT  

Herbal Medicines Today and the Roots of Modern Pharmacology
Goldman
ANN INTERN MED 2001;135:594-600.
ABSTRACT | FULL TEXT  

Hypocholesterolemic Effect of an Enteric-Coated Garlic Supplement
Kannar et al.
J. Am. Coll. Nutr. 2001;20:225-231.
ABSTRACT | FULL TEXT  

Gender May Affect the Action of Garlic Oil on Plasma Cholesterol and Glucose Levels of Normal Subjects
Zhang et al.
J. Nutr. 2001;131:1471-1478.
ABSTRACT | FULL TEXT  

Garlic Shows Promise for Improving Some Cardiovascular Risk Factors
Ackermann et al.
Arch Intern Med 2001;161:813-824.
ABSTRACT | FULL TEXT  

Intake of Garlic and Its Bioactive Components
Amagase et al.
J. Nutr. 2001;131:955S-962.
ABSTRACT | FULL TEXT  

Historical Perspective on Garlic and Cardiovascular Disease
Rahman
J. Nutr. 2001;131:977S-979.
ABSTRACT | FULL TEXT  

Aged Garlic Extract, a Modulator of Cardiovascular Risk Factors: A Dose-Finding Study on the Effects of AGE on Platelet Functions
Steiner and Li
J. Nutr. 2001;131:980S-984.
ABSTRACT | FULL TEXT  

Cholesterol-Lowering Effect of Garlic Extracts and Organosulfur Compounds: Human and Animal Studies
Yeh and Liu
J. Nutr. 2001;131:989S-993.
ABSTRACT | FULL TEXT  

Garlic for Treating Hypercholesterolemia: A Meta-Analysis of Randomized Clinical Trials
Stevinson et al.
ANN INTERN MED 2000;133:420-429.
ABSTRACT | FULL TEXT  

Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a)
Superko and Krauss
J Am Coll Cardiol 2000;35:321-326.
ABSTRACT | FULL TEXT  

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
Gibbons et al.
J Am Coll Cardiol 1999;33:2092-2197.
FULL TEXT  

Effect of Garlic on Serum Lipids
Lawson et al.
JAMA 1998;280:1568-1568.
FULL TEXT  

Alternative Medicine--Learning From the Past, Examining the Present, Advancing to the Future
Jonas
JAMA 1998;280:1616-1618.
FULL TEXT  

A Review of 12 Commonly Used Medicinal Herbs
O'Hara et al.
Arch Fam Med 1998;7:523-536.
ABSTRACT | FULL TEXT  

Garlic Oil Has No Effect on Lipids
JWatch General 1998;1998:9-9.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.